Published in Hepatitis Weekly, October 23rd, 2006
W. Zhang and colleagues, Fudan University, wrote that the study was done "to test the feasibility of delivering a plasmid encoding IL-15 as a DNA vaccine adjuvant for improving the immune responses induced by hepatitis B virus core gene DNA vaccine."
"We used RT-PCR based strategies to develop IL-15 expression constructs. We first confirmed that the gene could be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly